At a glance
ClinicalIndex Comparison RecordN/ACompleted· 29 enrolled
Drug / intervention
Radiation Segmentectomyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact of 90Yttrium (Y90) Radiation Segmentectomy on Hepatocellular Carcinoma and Cirrhosis
In Brief
A clinical study evaluating Radiation Segmentectomy for Hepatocellular Carcinoma. Completed, enrolled 29 participants across 1 site.
Detailed Summary
The aim of this pilot study is to assess the efficacy of radiation segmentectomy with Theraspheres in patients with unresectable hepatocellular carcinoma that would qualify for thermal ablation as per the BCLC guidelines, but are unable to receive thermal ablation due to unfavorable location of target lesions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatocellular Carcinoma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
First PostedAug 2017
Primary CompletionMar 2021
TodayJul 2026
First PostedAug 14, 2017
Enrollment StartAug 3, 2016
Primary CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 8.9 years ago
Interventions
Radiation Segmentectomyradiation
The administration of radioactivity in a branch of an artery of the liver